EXHIBIT 99.2



                            CERTIFICATION PURSUANT TO

                             18 U.S.C. SECTION 1350,

                             AS ADOPTED PURSUANT TO

                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



     In connection with the quarterly report of Nanobac Pharmaceuticals, Inc.
(the "Company") on Form 10-QSB for the period ending June 30, 2003 as filed with
the Securities and Exchange Commission on August 18, 2003 (the "Report"), I,
John D. Stanton, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of
2002, that:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.





/s/ John D. Stanton
- -------------------

John D. Stanton

Chief Financial Officer

August 18, 2003